Logo image of MDM.PA

MAISONS DU MONDE SA (MDM.PA) Stock Fundamental Analysis

Europe - EPA:MDM - FR0013153541 - Common Stock

2.11 EUR
+0.24 (+12.59%)
Last: 10/3/2025, 5:29:46 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MDM. MDM was compared to 57 industry peers in the Specialty Retail industry. MDM has a bad profitability rating. Also its financial health evaluation is rather negative. MDM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MDM had negative earnings in the past year.
In the past year MDM had a positive cash flow from operations.
MDM had positive earnings in 4 of the past 5 years.
MDM had a positive operating cash flow in each of the past 5 years.
MDM.PA Yearly Net Income VS EBIT VS OCF VS FCFMDM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

MDM has a Return On Assets of -11.35%. This is amonst the worse of the industry: MDM underperforms 80.70% of its industry peers.
MDM has a worse Return On Equity (-41.46%) than 80.70% of its industry peers.
Industry RankSector Rank
ROA -11.35%
ROE -41.46%
ROIC N/A
ROA(3y)-1.72%
ROA(5y)-0.18%
ROE(3y)-5.33%
ROE(5y)-0.77%
ROIC(3y)N/A
ROIC(5y)N/A
MDM.PA Yearly ROA, ROE, ROICMDM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Gross Margin of MDM (65.62%) is better than 94.74% of its industry peers.
In the last couple of years the Gross Margin of MDM has remained more or less at the same level.
MDM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.25%
MDM.PA Yearly Profit, Operating, Gross MarginsMDM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

MDM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MDM remains at a similar level compared to 1 year ago.
The number of shares outstanding for MDM has been reduced compared to 5 years ago.
Compared to 1 year ago, MDM has a worse debt to assets ratio.
MDM.PA Yearly Shares OutstandingMDM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MDM.PA Yearly Total Debt VS Total AssetsMDM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.65, we must say that MDM is in the distress zone and has some risk of bankruptcy.
MDM has a worse Altman-Z score (0.65) than 66.67% of its industry peers.
The Debt to FCF ratio of MDM is 11.56, which is on the high side as it means it would take MDM, 11.56 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 11.56, MDM perfoms like the industry average, outperforming 49.12% of the companies in the same industry.
MDM has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.03, MDM is doing worse than 70.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 11.56
Altman-Z 0.65
ROIC/WACCN/A
WACC3.08%
MDM.PA Yearly LT Debt VS Equity VS FCFMDM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.63 indicates that MDM may have some problems paying its short term obligations.
MDM has a Current ratio of 0.63. This is amonst the worse of the industry: MDM underperforms 84.21% of its industry peers.
MDM has a Quick Ratio of 0.63. This is a bad value and indicates that MDM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.25, MDM is doing worse than 84.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.25
MDM.PA Yearly Current Assets VS Current LiabilitesMDM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1

3. Growth

3.1 Past

The earnings per share for MDM have decreased strongly by -889.53% in the last year.
The Revenue for MDM has decreased by -10.98% in the past year. This is quite bad
The Revenue has been decreasing by -4.00% on average over the past years.
EPS 1Y (TTM)-889.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.55%
Revenue 1Y (TTM)-10.98%
Revenue growth 3Y-8.7%
Revenue growth 5Y-4%
Sales Q2Q%-9.7%

3.2 Future

MDM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.56% yearly.
The Revenue is expected to decrease by -0.60% on average over the next years.
EPS Next Y-76.58%
EPS Next 2Y9.26%
EPS Next 3Y10.23%
EPS Next 5Y2.56%
Revenue Next Year-8.39%
Revenue Next 2Y-3.28%
Revenue Next 3Y-1.61%
Revenue Next 5Y-0.6%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDM.PA Yearly Revenue VS EstimatesMDM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
MDM.PA Yearly EPS VS EstimatesMDM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDM. In the last year negative earnings were reported.
Also next year MDM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDM.PA Price Earnings VS Forward Price EarningsMDM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

MDM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MDM is cheaper than 94.74% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MDM is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.28
EV/EBITDA 3.05
MDM.PA Per share dataMDM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.26%
EPS Next 3Y10.23%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.42%, MDM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.15, MDM pays a better dividend. On top of this MDM pays more dividend than 100.00% of the companies listed in the same industry.
MDM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 6.42%

5.2 History

The dividend of MDM decreases each year by -33.70%.
Dividend Growth(5Y)-33.7%
Div Incr Years0
Div Non Decr Years0
MDM.PA Yearly Dividends per shareMDM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

MDM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1.39%
EPS Next 2Y9.26%
EPS Next 3Y10.23%
MDM.PA Yearly Income VS Free CF VS DividendMDM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

MAISONS DU MONDE SA

EPA:MDM (10/3/2025, 5:29:46 PM)

2.11

+0.24 (+12.59%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-25 2025-07-25
Earnings (Next)10-23 2025-10-23
Inst Owners48.44%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap82.69M
Analysts50
Price Target2.41 (14.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.42%
Yearly Dividend0.06
Dividend Growth(5Y)-33.7%
DP-1.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-30.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.32%
EPS NY rev (3m)-88.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF 1.28
P/OCF 0.94
P/B 0.21
P/tB N/A
EV/EBITDA 3.05
EPS(TTM)-4.34
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)1.65
FCFY78.03%
OCF(TTM)2.24
OCFY106.22%
SpS25.03
BVpS10.25
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.35%
ROE -41.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.62%
FCFM 6.58%
ROA(3y)-1.72%
ROA(5y)-0.18%
ROE(3y)-5.33%
ROE(5y)-0.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.25%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 11.56
Debt/EBITDA 1.75
Cap/Depr 8.68%
Cap/Sales 2.38%
Interest Coverage N/A
Cash Conversion 37.09%
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.25
Altman-Z 0.65
F-Score5
WACC3.08%
ROIC/WACCN/A
Cap/Depr(3y)24.05%
Cap/Depr(5y)25.74%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-889.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.55%
EPS Next Y-76.58%
EPS Next 2Y9.26%
EPS Next 3Y10.23%
EPS Next 5Y2.56%
Revenue 1Y (TTM)-10.98%
Revenue growth 3Y-8.7%
Revenue growth 5Y-4%
Sales Q2Q%-9.7%
Revenue Next Year-8.39%
Revenue Next 2Y-3.28%
Revenue Next 3Y-1.61%
Revenue Next 5Y-0.6%
EBIT growth 1Y-437.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5326.86%
EBIT Next 3Y309.49%
EBIT Next 5Y189.13%
FCF growth 1Y-60.97%
FCF growth 3Y-11.59%
FCF growth 5Y-6.1%
OCF growth 1Y-59.72%
OCF growth 3Y-13.81%
OCF growth 5Y-8.3%